Cytokines of the interleukin-1 family are emerging as one of the most important mediators of obesity and metabolic health, with diverse and often opposing roles in either driving inflammatory mechanisms associated with disease pathogenesis, e.g. IL-1β, or inhibiting inflammation and/or caloric intake to promote the maintenance of metabolic health, e.g. IL-33, IL-18 and IL-3717,24. Here, IL33 is linked to obesity disorder.